Walleye Trading’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
40,400
+16,400
+68% +$525K ﹤0.01% 1882
2025
Q4
$485K Sell
24,000
-20,100
-46% -$486K ﹤0.01% 2840
2025
Q3
$1.33M Buy
44,100
+33,900
+332% +$734K ﹤0.01% 2079
2025
Q2
$132K Buy
10,200
+1,100
+12% +$10.5K ﹤0.01% 3460
2025
Q1
$66.3K Sell
9,100
-82,500
-90% -$912K ﹤0.01% 3537
2024
Q4
$1.52M Buy
91,600
+63,700
+228% +$849K ﹤0.01% 1866
2024
Q3
$359K Buy
27,900
+24,900
+830% +$360K ﹤0.01% 2731
2024
Q2
$33.5K Sell
3,000
-22,800
-88% -$266K ﹤0.01% 3685
2024
Q1
$320K Buy
25,800
+14,700
+132% +$245K ﹤0.01% 3137
2023
Q4
$294K Buy
11,100
+300
+3% +$8.75K ﹤0.01% 3500
2023
Q3
$494K Sell
10,800
-300
-3% -$13.9K ﹤0.01% 2969
2023
Q2
$458K Buy
11,100
+4,100
+59% +$135K ﹤0.01% 2814
2023
Q1
$217K Buy
+7,000
New +$225K ﹤0.01% 3449

Other funds holding AEHR

Walleye Trading's AEHR Position: Q1 2026 in Review

Walleye Trading opened a new position in Aehr Test Systems (AEHR) in Q1 2026: 11,996 shares worth $445K. The stake represents ﹤0.01% of the portfolio and ranks #2667 among its holdings. This is a return to the name: Walleye Trading previously reported a position in AEHR as recently as Q4 2024.

Walleye Trading first reported a position in AEHR in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.08M in Q2 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Walleye Trading held 11,996 shares of Aehr Test Systems worth $445K as of Q1 2026.
  • Aehr Test Systems was a new Walleye Trading position in Q1 2026.
  • Aehr Test Systems made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2667 holding.
  • Walleye Trading first reported a position in Aehr Test Systems in Q1 2023 and has held it in 8 quarters since.
  • Walleye Trading's Aehr Test Systems position peaked at $1.08M in Q2 2023.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.